| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |